Skip to main content
Caplight Logo









Kinzbio

Kinzbio

Private
MontevideoHealthcare & Life Scienceshttps://www.kinzbio.com/

Last Round

Grant

Dec 16, 2024

Total Funding Raised

$150,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kinzbio is a biotechnology company that develops and commercializes phage-based precision antimicrobials to treat and prevent antibiotic-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

recombinant proteinsmonoclonal antibodiesphage therapyELISA kitspolyclonal antibodiescustom protein expressioncontract researchbiotech reagentsantimicrobial solutionslife science researchphage discoverylab suppliespersonalized medicinebio-reagentsresearch tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kinzbio Comparables

Compare Kinzbio with similar companies based on industry and business-model similarity.

Kinzbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sino Biological Inc.
82%
StressMarq Biosciences
80%
GeneTex, Inc.
77%

Kinzbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2024
GrantNov 18, 2024

Key People

Founding team and executive leadership

Gregorio Iraola

Chief Executive Officer, Co-founder

Founding Team

Debbie Durlacher

Chief Operating Officer

Executive Team

Kinzbio Investors

Notable investors and investment history

Kinzbio investors
InvestorRounds
INCATEGrant
Agencia Nacional de Investigación e InnovaciónGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 154% MoM, reaching 954.

  • Jun 3, 2025

    Grew 27% QoQ from 11 to 14 employees.

Kinzbio Filings

Explore SEC and related filing metadata, where available.

Kinzbio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kinzbio's valuation, stock price, and market status.

Is Kinzbio a public or private company?

Kinzbio is a private company.

What is the current stock price of Kinzbio?

Kinzbio is a private company with no public stock price. Caplight tracks Kinzbio's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Kinzbio worth (valuation)?

Valuation information for Kinzbio is not publicly available.

Can I buy Kinzbio stock?

Kinzbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kinzbio's last funding round?

Kinzbio's most recent funding round was Grant on December 16, 2024.

Who are the main investors in Kinzbio?

Key investors in Kinzbio include INCATE, Agencia Nacional de Investigación e Innovación.

Will Kinzbio IPO soon?

No public IPO plans have been announced for Kinzbio.

How can I track Kinzbio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kinzbio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontevideo
Employee Range13
Year Founded2021
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?